{"disease":{"id":"cephalic-duodenopancreatectomy","name":"cephalic duodenopancreatectomy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03991065","title":"Risk of GAstric Adenocarcinoma After Cephalic Duodenopancreatectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06852014","title":"Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}